Literature DB >> 12002647

CTX-m-3 beta-lactamase-producing Escherichia coli from Greece.

A Mavroidi1, E Tzelepi, V Miriagou, D Gianneli, N J Legakis, L S Tzouvelekis.   

Abstract

An Escherichia coli clinical strain resistant to all beta-lactams except carbapenems was isolated in a Greek hospital. Analysis of beta-lactamase content by isoelectric focusing, PCR assays specific for various bla genes, and DNA sequencing showed that the strain produced TEM-1, a Citrobacter freundii AmpC-related cephalosporinase, and CTX-M-3. The blaCTX.M-3 gene was carried by a 120-kb plasmid that was readily transferable to a susceptible E. coli host.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002647     DOI: 10.1089/10766290252913737

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  3 in total

Review 1.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

2.  Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.

Authors:  C C Papagiannitsis; S D Kotsakis; Z Tuma; M Gniadkowski; V Miriagou; J Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.

Authors:  M Edelstein; M Pimkin; I Palagin; I Edelstein; L Stratchounski
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.